| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1867 | 2015 |
| The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ... Alzheimer's & Dementia 7 (4), 386-395. e6, 2011 | 453 | 2011 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 430 | 2013 |
| Neurological manifestations of long-COVID syndrome: a narrative review MI Stefanou, L Palaiodimou, E Bakola, N Smyrnis, M Papadopoulou, ... Therapeutic advances in chronic disease 13, 20406223221076890, 2022 | 289 | 2022 |
| Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 259 | 2022 |
| Highly increased CSF tau protein and decreased β-amyloid (1–42) in sporadic CJD: a discrimination from Alzheimer's disease? E Kapaki, K Kilidireas, GP Paraskevas, M Michalopoulou, E Patsouris Journal of Neurology, Neurosurgery & Psychiatry 71 (3), 401-403, 2001 | 191 | 2001 |
| Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ... JAMA psychiatry 75 (1), 84-95, 2018 | 189 | 2018 |
| Cerebrospinal fluid tau, phospho‐tau181 and β‐amyloid1−42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease EN Kapaki, GP Paraskevas, NG Tzerakis, C Sfagos, A Seretis, ... European journal of neurology 14 (2), 168-173, 2007 | 174 | 2007 |
| Circulating interleukin‐15 and RANTES chemokine in Parkinson’s disease M Rentzos, C Nikolaou, E Andreadou, GP Paraskevas, A Rombos, ... Acta Neurologica Scandinavica 116 (6), 374-379, 2007 | 158 | 2007 |
| Update on vascular cognitive impairment associated with subcortical small-vessel disease A Wallin, GC Román, M Esiri, P Kettunen, J Svensson, GP Paraskevas, ... Journal of Alzheimer’s disease 62 (3), 1417-1441, 2018 | 152 | 2018 |
| Corticobasal degeneration and corticobasal syndrome: A review VC Constantinides, GP Paraskevas, PG Paraskevas, L Stefanis, E Kapaki Clinical parkinsonism & related disorders 1, 66-71, 2019 | 147 | 2019 |
| Circulating interleukin‐10 and interleukin‐12 in Parkinson’s disease M Rentzos, C Nikolaou, E Andreadou, GP Paraskevas, A Rombos, ... Acta Neurologica Scandinavica 119 (5), 332-337, 2009 | 131 | 2009 |
| Neurofilament ELISA validation A Petzold, A Altintas, L Andreoni, A Bartos, A Berthele, MA Blankenstein, ... Journal of immunological methods 352 (1-2), 23-31, 2010 | 125 | 2010 |
| The stroop effect in Greek healthy population: normative data for the Stroop Neuropsychological Screening Test I Zalonis, F Christidi, A Bonakis, E Kararizou, NI Triantafyllou, ... Archives of Clinical Neuropsychology 24 (1), 81-88, 2009 | 124 | 2009 |
| Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease-A consensus report A Wallin, E Kapaki, M Boban, S Engelborghs, DM Hermann, B Huisa, ... BMC neurology 17 (1), 102, 2017 | 113 | 2017 |
| CSF tau protein and β‐amyloid (1–42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population E Kapaki, GP Paraskevas, I Zalonis, C Zournas European Journal of Neurology 10 (2), 119-128, 2003 | 112 | 2003 |
| Increased cerebrospinal fluid tau protein in multiple sclerosis E Kapaki, GP Paraskevas, M Michalopoulou, K Kilidireas European neurology 43 (4), 228-232, 2000 | 108 | 2000 |
| Type 2 diabetes mellitus as a risk factor for Alzheimer’s disease: Review and meta-analysis A Athanasaki, K Melanis, I Tsantzali, MI Stefanou, S Ntymenou, ... Biomedicines 10 (4), 778, 2022 | 102 | 2022 |
| The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer’s disease E Kapaki, GP Paraskevas, E Emmanouilidou, K Vekrellis PloS one 8 (11), e81654, 2013 | 93 | 2013 |
| Plasma alpha-synuclein levels in patients with Parkinson’s disease: a systematic review and meta-analysis A Bougea, L Stefanis, GP Paraskevas, E Emmanouilidou, K Vekrelis, ... Neurological sciences 40 (5), 929-938, 2019 | 90 | 2019 |
